
Cerimon Pharmaceuticals: Developing and commercializing therapeutics for autoimmune diseases and pain, globally.
Cerimon Pharmaceuticals, founded with a mission to develop and commercialize innovative therapeutics, focuses on treating autoimmune diseases, inflammation, injuries, and lower back pain. The company operates in both the United States and Europe, aiming to improve patient outcomes through advanced biopharmaceutical solutions.
Notable affiliated individuals and investors include experienced professionals from the biopharmaceutical industry. Cerimon has achieved significant milestones in therapeutic development, contributing to advancements in the treatment of chronic conditions. The company's impact is marked by its commitment to addressing unmet medical needs and enhancing the quality of life for patients worldwide.

Cerium Pharmaceuticals
ceriumpharma.com

Ceramedix Holding
ceramedix.com

Marillion Pharmaceuticals

NeuroTherapeutics Pharma

Kinnear Pharmaceuticals
kinnearpharma.com

Nuon Therapeutics

Celtaxsys
celtaxsys.com

Cara Therapeutics

Catalyst Pharmaceuticals
catalystpharma.com

Citrine Medicine

Kiniksa Pharmaceuticals
kiniksa.com

Complexa
Kemia

Anthera Pharmaceuticals
anthera.com

Simcere Pharmaceutical
simcere.com
Companies similar to Cerimon Pharmaceuticals include Cerium Pharmaceuticals, Ceramedix Holding, Marillion Pharmaceuticals and NeuroTherapeutics Pharma.
Cerimon Pharmaceuticals was founded in 2004.
Cerimon Pharmaceuticals' headquarters is located in South San Francisco, CA, US.
Cerimon Pharmaceuticals' most recent funding round was for $233k (USD) in November 2010.
As of Nov 15, 2010, Cerimon Pharmaceuticals has raised a total of $72.7M (USD).
Cerimon Pharmaceuticals has 30 employees as of Feb 5, 2024.